The C‐terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure‐suppressant actions of prepro‐NPY overexpression in male rats. Issue 3 (27th October 2018)
- Record Type:
- Journal Article
- Title:
- The C‐terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure‐suppressant actions of prepro‐NPY overexpression in male rats. Issue 3 (27th October 2018)
- Main Title:
- The C‐terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure‐suppressant actions of prepro‐NPY overexpression in male rats
- Authors:
- Soud, Katia
Jørgensen, Søren Heide
Woldbye, David Paul Drucker
Sørensen, Andreas Toft - Abstract:
- Abstract: The full coding sequence of neuropeptide Y (NPY), prepro‐NPY, is sequentially metabolized into three peptides; an N‐terminus 28‐amino acid signaling peptide, the NPY peptide itself (NPY1‐36), and a 30‐amino acid C‐terminus peptide, known as the C‐terminal flanking peptide of neuropeptide‐Y (CPON). While the signaling peptide directs intracellular trafficking and NPY1‐36 is well characterized, the biological function of CPON is unknown. This is noteworthy because CPON is co‐stored and co‐released along with NPY1‐36 and could thus potentially serve important functions. To assess the role of CPON, we adapted a viral genetic approach using two different vector designs encoding NPY, but where the CPON coding sequence was excluded from one of the vectors. Thus, the effect of CPON was indirectly assessed. Male rats received intrahippocampal injections of either a vector encoding NPY1‐39 whose metabolism yields NPY1‐36 and not CPON, or a prepro‐NPY vector encoding both NPY1‐36 and CPON. A third vector encoding EGFP served as control. We subsequently studied to what extent CPON might affect seizure susceptibility and memory performance, respectively, to address two important questions to evaluate the potential of NPY gene therapy in epilepsy. Both NPY vectors, as compared to EGFP control, were found to be equally effective at suppressing acute kainate–induced seizures, and both did not influence learning and memory performance in the Morris water maze. Thus CPON itself doesAbstract: The full coding sequence of neuropeptide Y (NPY), prepro‐NPY, is sequentially metabolized into three peptides; an N‐terminus 28‐amino acid signaling peptide, the NPY peptide itself (NPY1‐36), and a 30‐amino acid C‐terminus peptide, known as the C‐terminal flanking peptide of neuropeptide‐Y (CPON). While the signaling peptide directs intracellular trafficking and NPY1‐36 is well characterized, the biological function of CPON is unknown. This is noteworthy because CPON is co‐stored and co‐released along with NPY1‐36 and could thus potentially serve important functions. To assess the role of CPON, we adapted a viral genetic approach using two different vector designs encoding NPY, but where the CPON coding sequence was excluded from one of the vectors. Thus, the effect of CPON was indirectly assessed. Male rats received intrahippocampal injections of either a vector encoding NPY1‐39 whose metabolism yields NPY1‐36 and not CPON, or a prepro‐NPY vector encoding both NPY1‐36 and CPON. A third vector encoding EGFP served as control. We subsequently studied to what extent CPON might affect seizure susceptibility and memory performance, respectively, to address two important questions to evaluate the potential of NPY gene therapy in epilepsy. Both NPY vectors, as compared to EGFP control, were found to be equally effective at suppressing acute kainate–induced seizures, and both did not influence learning and memory performance in the Morris water maze. Thus CPON itself does not appear to aid actions governed by vector–mediated overexpression of NPY1‐36 within the hippocampus. Whether CPON serves other important functions remains to be determined. Abstract : NPY gene therapy without CPON is equally effective as conventional NPY gene therapy to dampen acute seizures. … (more)
- Is Part Of:
- Journal of neuroscience research. Volume 97:Issue 3(2019)
- Journal:
- Journal of neuroscience research
- Issue:
- Volume 97:Issue 3(2019)
- Issue Display:
- Volume 97, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 97
- Issue:
- 3
- Issue Sort Value:
- 2019-0097-0003-0000
- Page Start:
- 362
- Page End:
- 372
- Publication Date:
- 2018-10-27
- Subjects:
- CPON -- gene therapy -- Hippocampus -- learning and memory -- Neuropeptide Y (NPY) -- seizures -- viral vectors
Neurobiology -- Periodicals
612 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4547 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/109668564 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jnr.24350 ↗
- Languages:
- English
- ISSNs:
- 0360-4012
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5022.090000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9451.xml